Recruiting
InvestigationalNo placebo
Study of ADCE-D01 for Patients with Metastatic or Unresectable Soft Tissue Sarcoma
InvestigationalNo placebo
- Substances:ADCE-D01
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:ADCE-D01
Find therapies in clinical trials near you – page 138
- recruiting
- 3 987
- countries
- 28
- conditions
- 2 109
3 987 trials recruiting28 European countries2 109 conditions coveredUpdated today
10 381 trials match your criteria
Recruiting
Oesophageal cancer metastatic+3
RecruitingStudy of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Registered drugNo placebo
Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Registered drugNo placebo
- Disease:Oesophageal cancer metastaticMetastatic gastric cancer+2
- Substances:CapecitabineCisplatin+5
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Capecitabine
Recruiting
Acute myeloid leukaemia+3
RecruitingStudy on the Safety and Effects of Inobrodib, Betamethasone Sodium Phosphate, and Dimethyl Fumarate in Patients with Advanced Blood and Bone Marrow Cancers
Registered drugNo placebo
Study on the Safety and Effects of Inobrodib, Betamethasone Sodium Phosphate, and Dimethyl Fumarate in Patients with Advanced Blood and Bone Marrow Cancers
Registered drugNo placebo
- Disease:Acute myeloid leukaemiaMyelodysplastic syndrome+2
- Substances:DaratumumabDexamethasone+5
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Daratumumab
Recruiting
Hormone-refractory prostate cancer
RecruitingStudy on Cannabidiol for Pain Relief in Patients with Advanced Prostate Cancer
Investigational
Study on Cannabidiol for Pain Relief in Patients with Advanced Prostate Cancer
Investigational
- Disease:Hormone-refractory prostate cancer
- Substances:Cannabidiol
Countries:
Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Cannabidiol
Recruiting
Colorectal cancer metastatic
RecruitingStudy on Fluorouracil and Drug Combination for Patients with Metastatic Colorectal Cancer to Evaluate Drug Sensitivity
Registered drugNo placebo
Study on Fluorouracil and Drug Combination for Patients with Metastatic Colorectal Cancer to Evaluate Drug Sensitivity
Registered drugNo placebo
- Disease:Colorectal cancer metastatic
- Substances:Fluorouracil
Countries:
Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Fluorouracil
Recruiting
Pancreatic carcinoma
RecruitingStudy of sotorasib with chemotherapy combination for adult patients with advanced pancreatic cancer who have KRAS p.
Registered drugNo placebo
Study of sotorasib with chemotherapy combination for adult patients with advanced pancreatic cancer who have KRAS p.
Registered drugNo placebo
- Disease:Pancreatic carcinoma
- Substances:Calcium FolinateFluorouracil+5
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Calcium Folinate
Recruiting
Chronic rhinosinusitis with nasal polyps
RecruitingStudy on Reducing Biologic Treatments Mepolizumab and Dupilumab for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps
Registered drugNo placebo
Study on Reducing Biologic Treatments Mepolizumab and Dupilumab for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps
Registered drugNo placebo
- Disease:Chronic rhinosinusitis with nasal polyps
- Substances:Dupilumab
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Dupilumab
Recruiting
Attention deficit hyperactivity disorder
RecruitingStudy on How Methylphenidate Works in Adults with ADHD, Comparing Those with and Without Obesity
Registered drugNo placebo
Study on How Methylphenidate Works in Adults with ADHD, Comparing Those with and Without Obesity
Registered drugNo placebo
- Disease:Attention deficit hyperactivity disorder
- Substances:Methylphenidate Hydrochloride
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Methylphenidate Hydrochloride
Recruiting
Alcohol abuse+1
RecruitingStudy on the Effects of Cannabidiol and Naltrexone on Alcohol Craving in Patients with Alcohol Dependence
Investigational
Study on the Effects of Cannabidiol and Naltrexone on Alcohol Craving in Patients with Alcohol Dependence
Investigational
- Disease:Alcohol abuseAlcohol use disorder
- Substances:Cannabidiol
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Cannabidiol
Recruiting
Infection prophylaxis
RecruitingStudy on Preventing Infections in ICU Patients with Interferon Gamma and Sodium Chloride
Registered drug
Study on Preventing Infections in ICU Patients with Interferon Gamma and Sodium Chloride
Registered drug
- Disease:Infection prophylaxis
- Substances:Sodium ChlorideRecombinant human interferon gamma 1B
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Sodium Chloride
Recruiting
Lung neoplasm malignant
RecruitingStudy on High Dose Dexamethasone for Reducing Post-Surgery Pain in Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery
Registered drugNo placebo
Study on High Dose Dexamethasone for Reducing Post-Surgery Pain in Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery
Registered drugNo placebo
- Disease:Lung neoplasm malignant
- Substances:Dexamethasone Disodium Phosphate
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Dexamethasone Disodium Phosphate
Recruiting
Relapsing-remitting multiple sclerosis
RecruitingStudy on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis
Registered drugNo placebo
Study on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis
Registered drugNo placebo
- Disease:Relapsing-remitting multiple sclerosis
- Substances:Dimethyl FumarateDiroximel Fumarate+7
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Dimethyl Fumarate